Eloxx Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2017	2016	2015	2014	2013 - 1998
Net Income	-36.07	-66.73	-34.58	-50.87	-47.19	-21.21	-5.8	-8.27	-18.06	-9.23	Upgrade
Depreciation & Amortization	0.7	0.96	0.57	0.56	0.22	0.04	0.04	0.09	0.18	0.35	Upgrade
Share-Based Compensation	3.02	9.17	8.67	11.34	0	0.1	0.08	0.16	0.48	1.3	Upgrade
Other Operating Activities	0.5	21.6	-2.83	-0.41	15.6	5.14	3.75	4.34	10.06	2.71	Upgrade
Operating Cash Flow	-31.85	-35	-28.17	-39.39	-31.37	-15.94	-1.93	-3.68	-7.34	-4.87	Upgrade
Capital Expenditures	-0.07	-0.09	0	-0.04	-0.24	-0.24	-0	0	-0.26	-0.63	Upgrade
Acquisitions	0	2.15	0	0	0	0.12	0	0	0	1.27	Upgrade
Change in Investments	-	-	-33.75	-100.96	-	-0.06	-	-	-	-	Upgrade
Other Investing Activities	-	-	67.54	67.48	-0.08	0.06	0.05	-	-	-	Upgrade
Investing Cash Flow	-0.07	2.06	33.79	-33.52	-0.32	-0.11	0.05	0	-0.26	0.65	Upgrade
Common Stock Issued	0	47.72	0	32.88	55.74	17.01	0	1.15	4.83	10.92	Upgrade
Other Financing Activities	8.81	3.07	-3.44	13.92	0.45	20.94	1.1	-	-	-2.19	Upgrade
Financing Cash Flow	8.81	50.79	-3.44	46.8	56.18	37.95	1.1	1.15	4.83	8.73	Upgrade
Net Cash Flow	-23.1	17.84	2.19	-26.12	24.5	21.9	-0.78	-2.52	-2.78	4.51	Upgrade
Free Cash Flow	-31.91	-35.09	-28.17	-39.43	-31.6	-16.17	-1.93	-3.68	-7.6	-5.5	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-	-	-4901.62%	-10139.04%	-5495.86%	Upgrade
Free Cash Flow Per Share	-14.73	-20.06	-28.08	-41.44	-38.97	-129.99	-66.41	-144.72	-421.97	-802.90	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.